NovaBridge Biosciences NBP
NASDAQ NBP
$1.37 0.00 (-0.36%)
At close: Sep 30, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Capital Expenditures (2019 - 2024)

Updated

NovaBridge Biosciences (NBP) reported Capital Expenditures of -$7,000 for FY2025, compared with -$48,000 in FY2024.

Analysis

NovaBridge Biosciences (NBP) Capital Expenditures (2019 - 2024) Analysis & Trends

Dating back to FY2017, NovaBridge Biosciences' Capital Expenditures record includes 9 years.

  • The FY2025 figure ranks as the highest annual Capital Expenditures in data going back to FY2017.
  • According to Business Quant data, Capital Expenditures came in at -$48,000 in FY2024, -$164,000 in FY2023, -$2.09 million in FY2022 and -$4.7 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 NovaBridge Biosciences 150.88 Mn 150.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -38,000.00
Sep 30, 2024 -1,000.00
Dec 31, 2020 -489,950.53
Sep 30, 2020 -668,359.95
Dec 31, 2019 -1.08 Mn
API Access

NovaBridge Biosciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NBP&period=max&api_key=YOUR_API_KEY